Haematologica:王福俤等巨噬细胞铁代谢稳态与炎症反应研究获进展

2012-06-20 上海生科院健康所 上海生科院健康所

近日,国际学术期刊Haematologica在线发表了营养所王福俤研究组的研究论文“Metalloreductase Steap3 coordinates the regulation of iron homeostasis and inflammatory responses”。该研究结果揭示Steap3在巨噬细胞中发挥铁离子还原作用,Steap3缺失可影响巨噬细胞铁分布、造成细胞内可利用铁减少

近日,国际学术期刊Haematologica在线发表了营养所王福俤研究组的研究论文“Metalloreductase Steap3 coordinates the regulation of iron homeostasis and inflammatory responses”。该研究结果揭示Steap3在巨噬细胞中发挥铁离子还原作用,Steap3缺失可影响巨噬细胞铁分布、造成细胞内可利用铁减少从而影响TLR4介导的免疫炎症通路。

Steap3(Six-transmembrane epithelial antigen of the prostate 3)是2005年通过基因定位克隆技术(positional cloning)发现的一个影响机体铁代谢的基因,它含有具有还原活性的保守区域。哺乳动物主要由肠道吸收铁离子,之后三价铁离子进入血液与转铁蛋白(transferrin, Tf)结合形成Tf-Fe,Tf-Fe与细胞表面的转铁蛋白受体(transferrin receptor, TfR)结合,通过内吞进入细胞形成内含体(endosome)。而内含体膜上的铁离子通道DMT1和TRPML1只能往细胞质中运送二价铁离子,所以在内含体中铁离子有一个从三价到二价的还原过程,有研究提示Steap3在造血细胞内发挥金属还原酶作用,但Steap3在其它细胞内的功能和作用机制报道较少。

王福俤研究员指导的博士研究生张帆等利用Steap3基因敲除小鼠模型和原代培养细胞模型,发现Steap3在巨噬细胞中表达明显高于家族其它成员,同时在Steap3缺失的细胞中,铁离子有异常的分布及含量。在Steap3敲除巨噬细胞中,铁的还原活性明显降低,虽然和正常细胞相比含有相当量铁,但是其胞质内可利用的铁却明显少于正常细胞。Steap3敲除小鼠表现为小细胞贫血症状,脾脏肿大,血红蛋白和红细胞压积明显低于正常小鼠,但是血清铁含量却和正常小鼠相当,肝脏和脾脏铁甚至高于正常小鼠。这表明Steap3的缺失造成了细胞内及整个机体铁分布和代谢异常。为了进一步研究Steap3是否在巨噬细胞免疫应答中起作用,研究人员用LPS分别刺激原代巨噬细胞和小鼠,结果发现,和STEAP其它家族成员相反,Steap3可以被LPS显著下调。而且Steap3敲除小鼠在LPS刺激下,血清铁没有像正常小鼠一样下调,肝脏和脾脏都比正常小鼠累积更多的铁,显示出异常的铁代谢。同时在Steap3敲除的巨噬细胞,LPS刺激后激活的由TLR4介导的Myd88非依赖性炎症通路明显减弱,这种减弱很有可能是由细胞内可利用铁减少引起的。

该研究首次发现Steap3参与巨噬细胞的铁离子还原作用,并揭示Steap3是介导铁代谢与免疫应答的重要分子,这为进一步研究铁代谢与免疫应答之间的相互调节的机制研究提供了丰富的实验依据,还为铁代谢与免疫关系研究提供了新的线索。

该项工作得到了国家科技部、国家自然科学基金委、中国科学院及上海市科委等经费资助。

doi:10.3324/haematol.2012.063974
PMC:
PMID:

Metalloreductase Steap3 coordinates the regulation of iron homeostasis and inflammatory responses

Fan Zhang, Yunlong Tao, Zhuzhen Zhang, Xin Guo, Peng An, Yuanyuan Shen, Qian Wu, Yu Yu and Fudi Wang*

Background Iron and its homeostasis are intimately tied to inflammatory responses, but the underlying molecular mechanisms are poorly understood. We investigated the role of Steap3 in regulating iron homeostasis in macrophages, and the effects of Steap3 depletion on host inflammatory responses. Design and Methods We analyzed bone marrow-derived macrophages and primary cultured hepatocytes from Steap3-/- mouse models to investigate the roles of Steap3 in coordinately regulating iron homeostasis and inflammatory responses. Firstly, we examined iron distribution and iron status in cells deficient for Steap3, as well as the requirement for this gene during inflammatory responses. Secondly, we analyzed the regulation of Steap3 expression by inflammatory stimuli and thus, the influence of these stimuli on iron distribution and homeostasis. Results We found that Steap3 mRNA was expressed at high levels in macrophages and hepatocytes. Steap3 deficiency led to impaired iron homeostasis, causing abnormal iron distribution and decreased available cytosolic iron in macrophages. Among STEAP family members, Steap3 mRNA was uniquely downregulated in LPS-stimulated macrophages. To determine if Steap3 regulated iron homeostasis during inflammatory stress, we treated Steap3-/- mice with lipopolysaccharide, which produced elevated iron accumulation in vital tissues relative to wild-type controls. Furthermore, Steap3 depletion led to impaired induction of IFN-β, MCP-5, and IP-10 in macrophages via the TLR4-mediated signaling pathway. Conclusions Steap3 is important in regulating both iron homeostasis and TLR4-mediated inflammatory responses in macrophages. Steap3 deficiency causes abnormal iron status and homeostasis, which leads to impaired TLR4-mediated inflammatory responses in macrophages. Following inflammatory stimuli, Steap3 depletion causes dysregulated iron sequestration and distribution. Our results provide important insights into the function of Steap3 as a coordinate regulator of both iron homeostasis and innate immunity.

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1801171, encodeId=434518011e17a, content=<a href='/topic/show?id=d4bce344265' target=_blank style='color:#2F92EE;'>#研究获进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73442, encryptionId=d4bce344265, topicName=研究获进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Tue Dec 04 07:21:00 CST 2012, time=2012-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1646689, encodeId=314016466893f, content=<a href='/topic/show?id=4478e5315e1' target=_blank style='color:#2F92EE;'>#稳态#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75315, encryptionId=4478e5315e1, topicName=稳态)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ebc23344390, createdName=changfy, createdTime=Mon Dec 24 10:21:00 CST 2012, time=2012-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2008194, encodeId=c1c220081944e, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8444, encryptionId=1066844469, topicName=HAE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32d177, createdName=changfy, createdTime=Wed Feb 13 02:21:00 CST 2013, time=2013-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1317183, encodeId=a6a2131e1832b, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6704, encryptionId=74916e0414, topicName=EMA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35a460, createdName=fengyi812, createdTime=Fri Jun 22 05:21:00 CST 2012, time=2012-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1320796, encodeId=829d1320e96b3, content=<a href='/topic/show?id=43de6e0076f' target=_blank style='color:#2F92EE;'>#炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67007, encryptionId=43de6e0076f, topicName=炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73f484, createdName=lsj628, createdTime=Fri Jun 22 05:21:00 CST 2012, time=2012-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507028, encodeId=b894150e02834, content=<a href='/topic/show?id=870c9653155' target=_blank style='color:#2F92EE;'>#铁代谢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96531, encryptionId=870c9653155, topicName=铁代谢)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d84f9850762, createdName=syscxl, createdTime=Fri Jun 22 05:21:00 CST 2012, time=2012-06-22, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1801171, encodeId=434518011e17a, content=<a href='/topic/show?id=d4bce344265' target=_blank style='color:#2F92EE;'>#研究获进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73442, encryptionId=d4bce344265, topicName=研究获进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Tue Dec 04 07:21:00 CST 2012, time=2012-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1646689, encodeId=314016466893f, content=<a href='/topic/show?id=4478e5315e1' target=_blank style='color:#2F92EE;'>#稳态#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75315, encryptionId=4478e5315e1, topicName=稳态)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ebc23344390, createdName=changfy, createdTime=Mon Dec 24 10:21:00 CST 2012, time=2012-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2008194, encodeId=c1c220081944e, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8444, encryptionId=1066844469, topicName=HAE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32d177, createdName=changfy, createdTime=Wed Feb 13 02:21:00 CST 2013, time=2013-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1317183, encodeId=a6a2131e1832b, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6704, encryptionId=74916e0414, topicName=EMA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35a460, createdName=fengyi812, createdTime=Fri Jun 22 05:21:00 CST 2012, time=2012-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1320796, encodeId=829d1320e96b3, content=<a href='/topic/show?id=43de6e0076f' target=_blank style='color:#2F92EE;'>#炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67007, encryptionId=43de6e0076f, topicName=炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73f484, createdName=lsj628, createdTime=Fri Jun 22 05:21:00 CST 2012, time=2012-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507028, encodeId=b894150e02834, content=<a href='/topic/show?id=870c9653155' target=_blank style='color:#2F92EE;'>#铁代谢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96531, encryptionId=870c9653155, topicName=铁代谢)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d84f9850762, createdName=syscxl, createdTime=Fri Jun 22 05:21:00 CST 2012, time=2012-06-22, status=1, ipAttribution=)]
    2012-12-24 changfy
  3. [GetPortalCommentsPageByObjectIdResponse(id=1801171, encodeId=434518011e17a, content=<a href='/topic/show?id=d4bce344265' target=_blank style='color:#2F92EE;'>#研究获进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73442, encryptionId=d4bce344265, topicName=研究获进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Tue Dec 04 07:21:00 CST 2012, time=2012-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1646689, encodeId=314016466893f, content=<a href='/topic/show?id=4478e5315e1' target=_blank style='color:#2F92EE;'>#稳态#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75315, encryptionId=4478e5315e1, topicName=稳态)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ebc23344390, createdName=changfy, createdTime=Mon Dec 24 10:21:00 CST 2012, time=2012-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2008194, encodeId=c1c220081944e, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8444, encryptionId=1066844469, topicName=HAE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32d177, createdName=changfy, createdTime=Wed Feb 13 02:21:00 CST 2013, time=2013-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1317183, encodeId=a6a2131e1832b, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6704, encryptionId=74916e0414, topicName=EMA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35a460, createdName=fengyi812, createdTime=Fri Jun 22 05:21:00 CST 2012, time=2012-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1320796, encodeId=829d1320e96b3, content=<a href='/topic/show?id=43de6e0076f' target=_blank style='color:#2F92EE;'>#炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67007, encryptionId=43de6e0076f, topicName=炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73f484, createdName=lsj628, createdTime=Fri Jun 22 05:21:00 CST 2012, time=2012-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507028, encodeId=b894150e02834, content=<a href='/topic/show?id=870c9653155' target=_blank style='color:#2F92EE;'>#铁代谢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96531, encryptionId=870c9653155, topicName=铁代谢)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d84f9850762, createdName=syscxl, createdTime=Fri Jun 22 05:21:00 CST 2012, time=2012-06-22, status=1, ipAttribution=)]
    2013-02-13 changfy
  4. [GetPortalCommentsPageByObjectIdResponse(id=1801171, encodeId=434518011e17a, content=<a href='/topic/show?id=d4bce344265' target=_blank style='color:#2F92EE;'>#研究获进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73442, encryptionId=d4bce344265, topicName=研究获进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Tue Dec 04 07:21:00 CST 2012, time=2012-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1646689, encodeId=314016466893f, content=<a href='/topic/show?id=4478e5315e1' target=_blank style='color:#2F92EE;'>#稳态#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75315, encryptionId=4478e5315e1, topicName=稳态)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ebc23344390, createdName=changfy, createdTime=Mon Dec 24 10:21:00 CST 2012, time=2012-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2008194, encodeId=c1c220081944e, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8444, encryptionId=1066844469, topicName=HAE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32d177, createdName=changfy, createdTime=Wed Feb 13 02:21:00 CST 2013, time=2013-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1317183, encodeId=a6a2131e1832b, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6704, encryptionId=74916e0414, topicName=EMA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35a460, createdName=fengyi812, createdTime=Fri Jun 22 05:21:00 CST 2012, time=2012-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1320796, encodeId=829d1320e96b3, content=<a href='/topic/show?id=43de6e0076f' target=_blank style='color:#2F92EE;'>#炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67007, encryptionId=43de6e0076f, topicName=炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73f484, createdName=lsj628, createdTime=Fri Jun 22 05:21:00 CST 2012, time=2012-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507028, encodeId=b894150e02834, content=<a href='/topic/show?id=870c9653155' target=_blank style='color:#2F92EE;'>#铁代谢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96531, encryptionId=870c9653155, topicName=铁代谢)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d84f9850762, createdName=syscxl, createdTime=Fri Jun 22 05:21:00 CST 2012, time=2012-06-22, status=1, ipAttribution=)]
    2012-06-22 fengyi812
  5. [GetPortalCommentsPageByObjectIdResponse(id=1801171, encodeId=434518011e17a, content=<a href='/topic/show?id=d4bce344265' target=_blank style='color:#2F92EE;'>#研究获进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73442, encryptionId=d4bce344265, topicName=研究获进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Tue Dec 04 07:21:00 CST 2012, time=2012-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1646689, encodeId=314016466893f, content=<a href='/topic/show?id=4478e5315e1' target=_blank style='color:#2F92EE;'>#稳态#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75315, encryptionId=4478e5315e1, topicName=稳态)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ebc23344390, createdName=changfy, createdTime=Mon Dec 24 10:21:00 CST 2012, time=2012-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2008194, encodeId=c1c220081944e, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8444, encryptionId=1066844469, topicName=HAE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32d177, createdName=changfy, createdTime=Wed Feb 13 02:21:00 CST 2013, time=2013-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1317183, encodeId=a6a2131e1832b, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6704, encryptionId=74916e0414, topicName=EMA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35a460, createdName=fengyi812, createdTime=Fri Jun 22 05:21:00 CST 2012, time=2012-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1320796, encodeId=829d1320e96b3, content=<a href='/topic/show?id=43de6e0076f' target=_blank style='color:#2F92EE;'>#炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67007, encryptionId=43de6e0076f, topicName=炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73f484, createdName=lsj628, createdTime=Fri Jun 22 05:21:00 CST 2012, time=2012-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507028, encodeId=b894150e02834, content=<a href='/topic/show?id=870c9653155' target=_blank style='color:#2F92EE;'>#铁代谢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96531, encryptionId=870c9653155, topicName=铁代谢)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d84f9850762, createdName=syscxl, createdTime=Fri Jun 22 05:21:00 CST 2012, time=2012-06-22, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1801171, encodeId=434518011e17a, content=<a href='/topic/show?id=d4bce344265' target=_blank style='color:#2F92EE;'>#研究获进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73442, encryptionId=d4bce344265, topicName=研究获进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ad8182, createdName=axin009, createdTime=Tue Dec 04 07:21:00 CST 2012, time=2012-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1646689, encodeId=314016466893f, content=<a href='/topic/show?id=4478e5315e1' target=_blank style='color:#2F92EE;'>#稳态#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75315, encryptionId=4478e5315e1, topicName=稳态)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ebc23344390, createdName=changfy, createdTime=Mon Dec 24 10:21:00 CST 2012, time=2012-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2008194, encodeId=c1c220081944e, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8444, encryptionId=1066844469, topicName=HAE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32d177, createdName=changfy, createdTime=Wed Feb 13 02:21:00 CST 2013, time=2013-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1317183, encodeId=a6a2131e1832b, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6704, encryptionId=74916e0414, topicName=EMA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35a460, createdName=fengyi812, createdTime=Fri Jun 22 05:21:00 CST 2012, time=2012-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1320796, encodeId=829d1320e96b3, content=<a href='/topic/show?id=43de6e0076f' target=_blank style='color:#2F92EE;'>#炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67007, encryptionId=43de6e0076f, topicName=炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73f484, createdName=lsj628, createdTime=Fri Jun 22 05:21:00 CST 2012, time=2012-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507028, encodeId=b894150e02834, content=<a href='/topic/show?id=870c9653155' target=_blank style='color:#2F92EE;'>#铁代谢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96531, encryptionId=870c9653155, topicName=铁代谢)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d84f9850762, createdName=syscxl, createdTime=Fri Jun 22 05:21:00 CST 2012, time=2012-06-22, status=1, ipAttribution=)]
    2012-06-22 syscxl

相关资讯

Blood:研究揭示铁泵蛋白Fpn1在铁代谢中作用

  6月24日,国际著名学术期刊《血液》(Blood)在线发表了中科院上海生命科学研究院营养所王福俤研究组的科研论文“Ferroportin1 deficiency in mouse macrophages impairs iron homeostasis and inflammatory responses”。该论文以小鼠为实验模型,通过在巨噬细胞中条件性敲除铁泵蛋白Ferropor